TCL Archive Treatment Progress Increases Five Year Survival To 41%; Rates Compared For 10 Leading Cancers April 25, 1980
TCL Archive MGI Pharma’s Irofulven In Phase III Trial Vs. 5-FU For Advanced Pancreatic Cancer. March 2, 2001
TCL Archive National Cancer Survey Data Available Soon: NCI Will Invite Investigators to Prepare Analysis August 23, 1974